Preoperative plasma level of IL-10 but not of proinflammatory cytokines is an independent prognostic factor in patients with gastric cancer
- PMID: 20044609
Preoperative plasma level of IL-10 but not of proinflammatory cytokines is an independent prognostic factor in patients with gastric cancer
Abstract
There have been many discrepant observations on the serum levels of cytokines in cancer patients and their prognostic value. The purpose of this study was to determine the plasma levels of pro- and anti-inflammatory cytokines and their clinical significance in a large group of patients with gastric carcinoma. The levels of tumour necrosis factor alpha (TNF alpha), interleukin-12p40 (IL-12p40), IL-12p70, IL-18, IL-10 and soluble TNF receptors I and II sTNF-Rs were investigated in the plasma of 136 consecutive patients with biopsy proven gastric cancer using specific enzyme-linked immunoabsorbent assays (ELISA). Survival curves were estimated using the method of Kaplan and Meier and the differences in the survival rates were tested by the log-rank test. For multivariate analysis of prognostic factors, the Cox proportional hazard model was used. Proinflammatory cytokines and sTNF-Rs were higher in the whole group of patients in comparison to healthy volunteers. IL-10 was elevated mostly in advanced disease. The increased levels of IL-10 (>10 pg/ml) were associated with significantly poorer survival of patients, while the levels of the other cytokines and sTNF-Rs showed no correlation with prognosis. The increased level of IL-10 is an independent unfavorable prognostic factor in patients with gastric cancer.
Similar articles
-
Soluble TNF and IL-2 receptors in patients with breast cancer.Med Sci Monit. 2000 Jul-Aug;6(4):661-7. Med Sci Monit. 2000. PMID: 11208388
-
Serum TIMP-1 in gastric cancer patients: a potential prognostic biomarker.Ann Clin Lab Sci. 2006 Winter;36(1):23-30. Ann Clin Lab Sci. 2006. PMID: 16501233
-
Prognostic value of circulating chromogranin A and soluble tumor necrosis factor receptors in advanced nonsmall cell lung cancer.Cancer. 2007 Aug 15;110(4):845-53. doi: 10.1002/cncr.22856. Cancer. 2007. PMID: 17599769
-
Prognostic value of circulating cytokines on overall survival and disease-free survival in cancer patients.Biomark Med. 2014;8(2):297-306. doi: 10.2217/bmm.13.122. Biomark Med. 2014. PMID: 24521026 Review.
-
[Clinical significance of interleukin-6 (IL-6) as a prognostic factor of cancer disease].Pol Arch Med Wewn. 2007 May-Jun;117(5-6):247-51. Pol Arch Med Wewn. 2007. PMID: 18030875 Review. Polish.
Cited by
-
IL-6/IL-10 mRNA expression ratio in tumor tissues predicts prognosis in gastric cancer patients without distant metastasis.Sci Rep. 2022 Nov 12;12(1):19427. doi: 10.1038/s41598-022-24189-3. Sci Rep. 2022. PMID: 36371539 Free PMC article.
-
Measurement of tumour necrosis factor receptors for immune response in colon cancer patients.Clin Exp Med. 2012 Dec;12(4):225-31. doi: 10.1007/s10238-011-0162-5. Epub 2011 Nov 1. Clin Exp Med. 2012. PMID: 22042432
-
Tumor growth limited to subcutaneous site vs tumor growth in pulmonary site exhibit differential effects on systemic immunities.Oncol Rep. 2017 Jul;38(1):449-455. doi: 10.3892/or.2017.5646. Epub 2017 May 17. Oncol Rep. 2017. PMID: 28535011 Free PMC article.
-
Roles of inflammatory cytokines in the progression of gastric cancer: friends or foes?Gastric Cancer. 2010 Nov;13(4):212-21. doi: 10.1007/s10120-010-0568-x. Epub 2010 Dec 3. Gastric Cancer. 2010. PMID: 21128056 Review.
-
Dysregulation of systemic immunity and its clinical application in gastric cancer.Front Immunol. 2024 Sep 5;15:1450128. doi: 10.3389/fimmu.2024.1450128. eCollection 2024. Front Immunol. 2024. PMID: 39301031 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous